Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive factors of achieving therapeutic goals of hypertriglyceridemia.
Pintó X, Valdivielso P, Perez de Juan JM, Plana N, Garcia-Arias C, Fuentes FJ, Hernández-Mijares A, Mostaza JM; Spanish Registry of Hypertriglyceridemia (Spanish Society of Arteriosclerosis, SAS). Pintó X, et al. Among authors: plana n. Curr Med Res Opin. 2014 Jan;30(1):19-26. doi: 10.1185/03007995.2013.850069. Epub 2013 Oct 18. Curr Med Res Opin. 2014. PMID: 24083660
Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X. Alvarez-Sala LA, et al. Among authors: plana n. Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013. Clin Ther. 2008. PMID: 18343245 Clinical Trial.
[Clinical features of patients with hypertriglyceridemia referred to lipid units: registry of hypertrigliceridemia of the Spanish Arteriosclerosis Society].
Valdivielso P, Pintó X, Mateo-Gallego R, Masana L, Alvarez-Sala L, Jarauta E, Suárez M, García-Arias C, Plana N, Laguna F; Registro de HTG de la SEA. Valdivielso P, et al. Among authors: plana n. Med Clin (Barc). 2011 Mar 12;136(6):231-8. doi: 10.1016/j.medcli.2010.09.028. Epub 2011 Jan 15. Med Clin (Barc). 2011. PMID: 21239026 Spanish.
How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
Masana L, Plana N, Pérez-Calahorra S, Ibarretxe D, Lamiquiz-Moneo I, Pedro-Botet J, Suárez-Tembra M, Valdivielso P, Ortega E, Civeira F; Dyslipidemia Registry of the Spanish Arteriosclerosis Society. Masana L, et al. Among authors: plana n. Atherosclerosis. 2017 Jul;262:107-112. doi: 10.1016/j.atherosclerosis.2017.05.013. Epub 2017 May 12. Atherosclerosis. 2017. PMID: 28531826
Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting.
Martín-Campos JM, Plana N, Figueras R, Ibarretxe D, Caixàs A, Esteve E, Pérez A, Bueno M, Mauri M, Roig R, Martínez S, Pintó X, Masana L, Julve J, Blanco-Vaca F; Xarxa d’Unitats de Lípids i Arteriosclerosi (XULA). Martín-Campos JM, et al. Among authors: plana n. J Clin Lipidol. 2018 Nov-Dec;12(6):1452-1462. doi: 10.1016/j.jacl.2018.09.002. Epub 2018 Sep 7. J Clin Lipidol. 2018. PMID: 30293936
Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia.
Perez-Calahorra S, Laclaustra M, Marco-Benedí V, Lamiquiz-Moneo I, Pedro-Botet J, Plana N, Sanchez-Hernandez RM, Amor AJ, Almagro F, Fuentes F, Suarez-Tembra M, Civeira F; Dyslipemia Registry of Spanish Arteriosclerosis Society. Perez-Calahorra S, et al. Among authors: plana n. Atherosclerosis. 2019 May;284:245-252. doi: 10.1016/j.atherosclerosis.2019.02.003. Epub 2019 Feb 12. Atherosclerosis. 2019. PMID: 30827715 Free article.
192 results